Clinical Trial Update: Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma [NA]

View source ↗

Summary

A completed clinical trial update describes a diagnostic study designed to predict the risk of metastatic cancer in patients with Stage I or Stage II melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Melanoma (Skin) | NA | Status: COMPLETED